In vivo evaluation of mutant selection window of cefquinome against Escherichia coli in piglet tissue-cage model.
about
Determination of the Mutant Selection Window and Evaluation of the Killing of Mycoplasma gallisepticum by Danofloxacin, Doxycycline, Tilmicosin, Tylvalosin and ValnemulinIntegrated pharmacokinetic-Pharmacodynamic (PK/PD) model to evaluate the in vivo antimicrobial activity of Marbofloxacin against Pasteurella multocida in piglets.Pharmacokinetic/Pharmacodynamic Modeling of Tulathromycin against Pasteurella multocida in a Porcine Tissue Cage Model.Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of ceftiofur after a single intravenous, subcutaneous and subcutaneous-LA administration in lactating goats.In vitro susceptibility of four antimicrobials against Riemerella anatipestifer isolates: a comparison of minimum inhibitory concentrations and mutant prevention concentrations for ceftiofur, cefquinome, florfenicol, and tilmicosin.Relationship between Cefquinome PK/PD Parameters and Emergence of Resistance of Staphylococcus aureus in Rabbit Tissue-Cage Infection Model.Plasma and synovial fluid pharmacokinetics of cefquinome following the administration of multiple doses in horses.In Vitro Resistance Selection in Shigella flexneri by Azithromycin, Ceftriaxone, Ciprofloxacin, Levofloxacin, and Moxifloxacin.Suppression of reactive-oxygen-species accumulation accounts for paradoxical bacterial survival at high quinolone concentration.Pharmacokinetic/Pharmacodynamic Integration to Evaluate the Changes in Susceptibility of After Repeated Administration of DanofloxacinRelationship between danofloxacin PK/PD parameters and emergence and mechanism of resistance of Mycoplasma gallisepticum in In Vitro model
P2860
Q28468397-4313CED0-19C1-4A8D-9EB3-4D6DD76CD3F0Q33802390-7B586BB1-E454-475C-999E-552B2B6280B4Q33843052-5FFE0A39-5800-4108-989D-770C065E18BDQ36163141-6F4A43D6-A121-43AE-A338-CEE4EFDD2CCCQ36187937-A7DDA33C-7FEE-432C-8F0C-20F822DDF905Q36976649-B668CD0D-EAAD-422B-9679-5B23AC9DBAEEQ39376296-A8A22D5F-C104-4396-9466-DFB89D82BF45Q40220956-A4F54B01-79E3-49C1-B68F-5D0799E3ED7CQ46243490-47910C35-90F1-4D78-97AD-925709D5D70CQ58123039-548A59CE-C154-4B83-92AD-957151A7F4D0Q58696539-48C9B5A2-3FA8-4125-A131-75CE37588522
P2860
In vivo evaluation of mutant selection window of cefquinome against Escherichia coli in piglet tissue-cage model.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
In vivo evaluation of mutant s ...... i in piglet tissue-cage model.
@ast
In vivo evaluation of mutant s ...... i in piglet tissue-cage model.
@en
In vivo evaluation of mutant s ...... i in piglet tissue-cage model.
@nl
type
label
In vivo evaluation of mutant s ...... i in piglet tissue-cage model.
@ast
In vivo evaluation of mutant s ...... i in piglet tissue-cage model.
@en
In vivo evaluation of mutant s ...... i in piglet tissue-cage model.
@nl
prefLabel
In vivo evaluation of mutant s ...... i in piglet tissue-cage model.
@ast
In vivo evaluation of mutant s ...... i in piglet tissue-cage model.
@en
In vivo evaluation of mutant s ...... i in piglet tissue-cage model.
@nl
P2093
P2860
P1476
In vivo evaluation of mutant s ...... i in piglet tissue-cage model.
@en
P2093
Bingxu Zhang
Huanzhong Ding
Mengxiao Gu
Xiangguang Shen
Xiaohong Li
Xiaoyan Gu
P2860
P2888
P356
10.1186/S12917-014-0297-1
P577
2014-12-16T00:00:00Z
P5875
P6179
1050982815